Several in vitro assays, such as AChE inhibition, BuChE inhibition, antioxidant activity, MAO-B inhibition, and MAO-A inhibition were performed to evaluate the synthetic oxadiazole derivatives’ potential to treat AD. This evidence concerns the gene MAOB and Alzheimer disease.